Business Context and Reporting Period
This Form 8-K was filed by Reviv3 Procare Company (noted as Axil Brands, Inc. in request metadata) on October 12, 2022. The filing serves to announce the company's financial results for the three-month period ended August 31, 2022. The registrant is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in the text of this filing. The document solely references the issuance of the press release regarding the period ended August 31, 2022.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, specific risk factors, or discussion of contingencies. It explicitly states that the information in the attached press release is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting its legal liability status within this specific document.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for actual revenue, net income, and cash flow figures.
- Verify the discrepancy between the request metadata name ("Axil Brands, Inc.") and the registrant name in the filing ("Reviv3 Procare Company").
- Confirm the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Note that the financial data in the press release is not deemed "filed" under Section 18 of the Exchange Act.